The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report

Upile, Tahwinder; Jerjes, Waseem; Mahil, Jaspal; Hopper, Colin; Sudhoff, Holger

The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report

Upile T, Jerjes W, Mahil J, Hopper C, Sudhoff H (2012)
Lasers in Medical Science 27(1): 257-260.

Zeitschriftenaufsatz | Veröffentlicht | Englisch

Download

Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!

DOI

https://doi.org/10.1007/s10103-011-0919-9

Autor*in

Upile, Tahwinder; Jerjes, Waseem; Mahil, Jaspal; Hopper, Colin; Sudhoff, Holger^UniBi

Einrichtung

Medizinische Fakultät OWL > AG 202 Hals-Nasen-Ohrenheilkunde

Erscheinungsjahr

2012

Zeitschriftentitel

Lasers in Medical Science

Band

27

Ausgabe

1

Seite(n)

257-260

ISSN

0268-8921

eISSN

1435-604X

Page URI

https://pub.uni-bielefeld.de/record/2951901

Zitieren

Upile T, Jerjes W, Mahil J, Hopper C, Sudhoff H. The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report. Lasers in Medical Science. 2012;27(1):257-260.

Upile, T., Jerjes, W., Mahil, J., Hopper, C., & Sudhoff, H. (2012). The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report. Lasers in Medical Science, 27(1), 257-260. https://doi.org/10.1007/s10103-011-0919-9

Upile, Tahwinder, Jerjes, Waseem, Mahil, Jaspal, Hopper, Colin, and Sudhoff, Holger. 2012. “The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report”. Lasers in Medical Science 27 (1): 257-260.

Upile, T., Jerjes, W., Mahil, J., Hopper, C., and Sudhoff, H. (2012). The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report. Lasers in Medical Science 27, 257-260.

Upile, T., et al., 2012. The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report. Lasers in Medical Science, 27(1), p 257-260.

T. Upile, et al., “The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report”, Lasers in Medical Science, vol. 27, 2012, pp. 257-260.

Upile, T., Jerjes, W., Mahil, J., Hopper, C., Sudhoff, H.: The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report. Lasers in Medical Science. 27, 257-260 (2012).

Upile, Tahwinder, Jerjes, Waseem, Mahil, Jaspal, Hopper, Colin, and Sudhoff, Holger. “The use of optical technology to monitor the antiangiogenic effects of gefitinib treatment for advanced head and neck squamous cell carcinoma: a brief report”. Lasers in Medical Science 27.1 (2012): 257-260.

Daten bereitgestellt von European Bioinformatics Institute (EBI)